Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV Vaccination in HBsAg-negative Chronic HBV Patients
NCT03405597Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Mar 2017
- Primary completion
- Feb 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis B vaccine recombinant in hepatitis B (HBV), sponsored by Mahidol University. Status: unknown.
02
Drugs
hepatitis B vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03405597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405597.